비침습적 출생전 검사 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Noninvasive Prenatal Testing Market size is expected to reach USD 20.30 Billion in 2034 from USD 6.09 Billion (2025) growing at a CAGR of 14.31% during 2026-2034.

The global noninvasive prenatal testing (NIPT) market is growing significantly due to increasing awareness about early detection of fetal genetic abnormalities. NIPT provides a safe and accurate alternative to invasive procedures, minimizing risks for both mother and fetus. The growing emphasis on early diagnosis and preventive healthcare has played a key role in driving adoption globally.

Key drivers include advancements in genomic sequencing technologies and the rising average maternal age, which increases the risk of chromosomal disorders. Government initiatives promoting prenatal screening and improved access to healthcare services are also supporting market expansion. Additionally, increasing healthcare awareness in emerging economies is contributing to higher adoption rates.

In the future, the market is expected to witness advancements in testing capabilities, enabling detection of a broader range of genetic conditions. Improved affordability and accessibility will further expand its reach. As healthcare systems prioritize early and noninvasive diagnostics, NIPT is likely to become a standard practice in prenatal care worldwide.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product and Services

• Products
• Services

By Method

• Ultrasound Detection
• Biochemical Screening Test
• Cell-Free DNA in Maternal Plasma Tests

By Application

• Trisomy
• Microdeletion Syndrome
• Other

By Test Type

• Materni21
• Harmony
• Panorama
• Verify
• NIFTY
• Others

By Technology

• NGS
• WGS
• Others

By End User

• Diagnostic Laboratories
• Hospitals

COMPANIES PROFILED

• Illumina Inc, Thermo Fisher Scientific Inc, General Electric, BGI Group, Agilent Technologies Inc, F HoffmannLa Roche Ltd, PerkinElmer Inc, Laboratory Corporation of America Holdings, Natera Inc, Yourgene Health, Eurofins LifeCodexx GmbH
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NONINVASIVE PRENATAL TESTING MARKET: BY PRODUCT AND SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product And Services
• 4.2. Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NONINVASIVE PRENATAL TESTING MARKET: BY METHOD 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Method
• 5.2. Ultrasound Detection Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Biochemical Screening Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Cell-Free DNA in Maternal Plasma Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NONINVASIVE PRENATAL TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Trisomy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Microdeletion Syndrome Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NONINVASIVE PRENATAL TESTING MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Test Type
• 7.2. Materni21 Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Harmony Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Panorama Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Verify Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. NIFTY Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL NONINVASIVE PRENATAL TESTING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Technology
• 8.2. NGS Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. WGS Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL NONINVASIVE PRENATAL TESTING MARKET: BY END USER 2022-2034 (USD MN)

• 9.1. Market Analysis, Insights and Forecast End User
• 9.2. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL NONINVASIVE PRENATAL TESTING MARKET: BY REGION 2022-2034 (USD MN)

• 10.1. Regional Outlook
• 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.2.1 By Product And Services
  • 10.2.2 By Method
  • 10.2.3 By Application
  • 10.2.4 By Test Type
  • 10.2.5 By Technology
  • 10.2.6 By End User
  • 10.2.7 United States
  • 10.2.8 Canada
  • 10.2.9 Mexico
• 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.3.1 By Product And Services
  • 10.3.2 By Method
  • 10.3.3 By Application
  • 10.3.4 By Test Type
  • 10.3.5 By Technology
  • 10.3.6 By End User
  • 10.3.7 United Kingdom
  • 10.3.8 France
  • 10.3.9 Germany
  • 10.3.10 Italy
  • 10.3.11 Russia
  • 10.3.12 Rest Of Europe
• 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.4.1 By Product And Services
  • 10.4.2 By Method
  • 10.4.3 By Application
  • 10.4.4 By Test Type
  • 10.4.5 By Technology
  • 10.4.6 By End User
  • 10.4.7 India
  • 10.4.8 Japan
  • 10.4.9 South Korea
  • 10.4.10 Australia
  • 10.4.11 South East Asia
  • 10.4.12 Rest Of Asia Pacific
• 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.5.1 By Product And Services
  • 10.5.2 By Method
  • 10.5.3 By Application
  • 10.5.4 By Test Type
  • 10.5.5 By Technology
  • 10.5.6 By End User
  • 10.5.7 Brazil
  • 10.5.8 Argentina
  • 10.5.9 Peru
  • 10.5.10 Chile
  • 10.5.11 Rest of Latin America
• 10.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.6.1 By Product And Services
  • 10.6.2 By Method
  • 10.6.3 By Application
  • 10.6.4 By Test Type
  • 10.6.5 By Technology
  • 10.6.6 By End User
  • 10.6.7 Saudi Arabia
  • 10.6.8 UAE
  • 10.6.9 Israel
  • 10.6.10 South Africa
  • 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

• 11.1. Recent Developments
• 11.2. Company Categorization
• 11.3. Supply Chain & Channel Partners (based on availability)
• 11.4. Market Share & Positioning Analysis (based on availability)
• 11.5. Vendor Landscape (based on availability)
• 11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL NONINVASIVE PRENATAL TESTING INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Company Profiles
  • 12.2.1 Illumina Inc
  • 12.2.2 Thermo Fisher Scientific Inc
  • 12.2.3 General Electric
  • 12.2.4 BGI Group
  • 12.2.5 Agilent Technologies Inc
  • 12.2.6 F. Hoffmann-La Roche Ltd
  • 12.2.7 PerkinElmer Inc
  • 12.2.8 Laboratory Corporation Of America Holdings
  • 12.2.9 Natera Inc
  • 12.2.10 Yourgene Health
  • 12.2.11 Eurofins LifeCodexx GmbH